SARINYAPINNGAM/iStock via Getty Images
Telix Pharmaceuticals (OTCPK:TLPPF) is set to enhance its North American manufacturing footprint and establish the basis of a “next generation radiometal production network” by acquiring RLS, America’s only Joint Commission-accredited radiopharmacy network, from its parent company, RLS Group Ltd., for $250M.
The purchase
Source link : http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=66f1074a275447b5842309703671bb75&url=https%3A%2F%2Fseekingalpha.com%2Fnews%2F4151781-telix-expands-its-north-american-manufacturing-footprint-with-acquisition-of-rls-for-250m&c=8269921448584403096&mkt=en-us
Author :
Publish date : 2024-09-22 19:10:00
Copyright for syndicated content belongs to the linked Source.